Intuitive Machines will study challenges related to carrying cargo on its lunar lander and hauling cargo on the moon. Photo courtesy of NASA

Houston-based space exploration, infrastructure, and services company Intuitive Machines has secured about $2.5 million from NASA to study challenges related to carrying cargo on the company’s lunar lander and hauling cargo on the moon. The lander will be used for NASA’s Artemis missions to the moon and eventually to Mars.

“Intuitive Machines has been methodically working on executing lunar delivery, data transmission, and infrastructure service missions, making us uniquely positioned to provide strategies and concepts that may shape lunar logistics and mobility solutions for the Artemis generation,” Intuitive Machines CEO Steve Altemus says in a news release.

“We look forward to bringing our proven expertise together to deliver innovative solutions that establish capabilities on the [moon] and place deeper exploration within reach.”

Intuitive Machines will soon launch its lunar lander on a SpaceX Falcon 9 rocket to deliver NASA technology and science projects, along with commercial payloads, to the moon’s Mons Mouton plateau. Lift-off will happen at NASA’s Kennedy Space Center in Florida within a launch window that starts in late February. It’ll be the lander’s second trip to the moon.

In September, Intuitive Machines landed a deal with NASA that could be worth more than $4.8 billion.

Under the contract, Intuitive Machines will supply communication and navigation services for missions in the “near space” region, which extends from the earth’s surface to beyond the moon.

The five-year deal includes an option to add five years to the contract. The initial round of NASA funding runs through September 2029.

The new exhibit is the first of its kind and will be open later this summer. Courtesy of Space Center Houston

New SpaceX exhibit expected to land at Space Center Houston this summer

Mission control

Space Center Houston has a new exhibit launching this summer. The nonprofit will have a Falcon 9 first stage booster on display starting later this summer.

The booster was used in two missions, which marked the first time a refurbished booster was used on a NASA mission. It first launched in June 2017 with a commercial resupply mission (CRS-11) and returned successfully to Earth. Then, the booster was flown a second time in December 2017 (CRS-13).

"We're excited to welcome Falcon 9 to our growing center," says William T. Harris, president and CEO of Space Center Houston, in a release. "It's part of an historic achievement designing a reusable rocket to further space exploration and America's commercial space industry. The new exhibit is one way we're interpreting the future of human spaceflight. We are deeply grateful to SpaceX for their contribution."

The booster, B1035, is one of only two of its kind on display, and the exhibit is the first commercial space exhibit for the museum. The booster will be displayed near Independence Plaza and will be presented on its side and raised 14 feet so that visitors can walk underneath it and learn about reusable technology in space and how it's making space travel more accessible.

NASA's Space Shuttle Program was the first to bring reusable spacecraft into existence, which lead to more accessibility and the creation of important advances in space technology, such as the International Space Station. SpaceX is continuing this technology within the commercial realm of space travel.

The exhibit was announced at Space Center Houston's Galaxy Gala presented by Chevron on Thursday, May 9. The event was led by co-chairs Peggy Kostial with Shanell and Walker Moody. Guests at the event enjoyed special presentations and sneak peeks, while raising nearly $700,000 for the Manned Space Flight Education Foundation. The proceeds will support the nonprofit's extensive education programs that benefits serving youth and educators from around the world.

"We strive to inspire youth to be part of the NASA mission," says Harris in the release. "From launching a rocket to designing a future spacecraft, we want everyone to have exceptional learning opportunities and to think outside the box like a scientist, engineer or astronaut. Thank you to our generous sponsors and donors whose contributions help us provide authentic learning experiences to people of all ages."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.